These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1233 related items for PubMed ID: 3104389

  • 1. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE, Macchi M, Montanini V, Mongioi A, Maugeri G, Vicari E, Coniglione F, Sipione C, D'Agata R.
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [Abstract] [Full Text] [Related]

  • 2. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D, Steingold K, Cedars M, Lu JK, Meldrum DR, Judd HL, Chang RJ.
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [Abstract] [Full Text] [Related]

  • 3. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome.
    Judd HL, Rigg LA, Anderson DC, Yen SS.
    J Clin Endocrinol Metab; 1976 Aug; 43(2):347-55. PubMed ID: 950366
    [Abstract] [Full Text] [Related]

  • 4. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [Abstract] [Full Text] [Related]

  • 5. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A, Mandeli J, Fluhr H, Dobrjansky A.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist.
    Chang RJ, Laufer LR, Meldrum DR, DeFazio J, Lu JK, Vale WW, Rivier JE, Judd HL.
    J Clin Endocrinol Metab; 1983 May; 56(5):897-903. PubMed ID: 6403570
    [Abstract] [Full Text] [Related]

  • 10. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
    Bhasin S, Heber D, Steiner BS, Handelsman DJ, Swerdloff RS.
    J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
    [Abstract] [Full Text] [Related]

  • 11. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC, Pache TD, Lamberts SW, Hop WC, de Jong FH, Dahl KD.
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [Abstract] [Full Text] [Related]

  • 12. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
    Klibanski A, Jameson JL, Biller BM, Crowley WF, Zervas NT, Rivier J, Vale WW, Bikkal H.
    J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
    [Abstract] [Full Text] [Related]

  • 13. Effects of gonadotropin-releasing hormone administration on the pituitary-gonadal axis in male and female dogs before and after gonadectomy.
    de Gier J, Buijtels JJ, Albers-Wolthers CH, Oei CH, Kooistra HS, Okkens AC.
    Theriogenology; 2012 Mar 15; 77(5):967-78. PubMed ID: 22153274
    [Abstract] [Full Text] [Related]

  • 14. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions.
    Pagán YL, Srouji SS, Jimenez Y, Emerson A, Gill S, Hall JE.
    J Clin Endocrinol Metab; 2006 Apr 15; 91(4):1309-16. PubMed ID: 16434454
    [Abstract] [Full Text] [Related]

  • 15. The rapid ovarian secretory response to pituitary stimulation by the gonadotropin-releasing hormone agonist nafarelin in sexual precocity.
    Rosenfield RL, Garibaldi LR, Moll GW, Watson AC, Burstein S.
    J Clin Endocrinol Metab; 1986 Dec 15; 63(6):1386-9. PubMed ID: 2946712
    [Abstract] [Full Text] [Related]

  • 16. Changing pituitary reactivity to follicle-stimulating hormone and luteinizing hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with polycystic ovarian disease.
    Blankstein J, Rabinovici J, Goldenberg M, Shaley J, Mehta A, Serr DM, Mashiach S.
    J Clin Endocrinol Metab; 1987 Dec 15; 65(6):1164-7. PubMed ID: 3119650
    [Abstract] [Full Text] [Related]

  • 17. Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase.
    Sagnella F, Apa R, Guido M, Villa P, Spadoni V, Miceli F, Lanzone A.
    Fertil Steril; 2009 May 15; 91(5):1857-63. PubMed ID: 18538325
    [Abstract] [Full Text] [Related]

  • 18. Chronic hyperestrogenemia: lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action.
    Richardson DW, Gordon K, Billiar RB, Little AB.
    Endocrinology; 1992 Mar 15; 130(3):1090-6. PubMed ID: 1537275
    [Abstract] [Full Text] [Related]

  • 19. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome.
    Barnes RB, Rosenfield RL, Burstein S, Ehrmann DA.
    N Engl J Med; 1989 Mar 02; 320(9):559-65. PubMed ID: 2521688
    [Abstract] [Full Text] [Related]

  • 20. "Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis.
    Meldrum DR, Chang RJ, Lu J, Vale W, Rivier J, Judd HL.
    J Clin Endocrinol Metab; 1982 May 02; 54(5):1081-3. PubMed ID: 6801075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.